menu
    • menu

    Company profile for Incyte Corporation

    NEW Drugs in Dev: 68
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Incyte's vision is to become a leading biopharmaceutical company by building a proprietary pipeline of novel small molecule drugs for serious unmet medical needs primarily in the area of oncology. The field of oncology is evolving rapidly and transforming how cancer is and will be treated. With a growing pipeline that includes innovative compounds in three major oncology areas -- onco-inflammation, immuno-oncology and targeted...
    Incyte's vision is to become a leading biopharmaceutical company by building a proprietary pipeline of novel small molecule drugs for serious unmet medical needs primarily in the area of oncology. The field of oncology is evolving rapidly and transforming how cancer is and will be treated. With a growing pipeline that includes innovative compounds in three major oncology areas -- onco-inflammation, immuno-oncology and targeted therapies -- we believe Incyte is at the center of this transformation in cancer care.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Incyte CorporationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1801 Augustine Cut-off Wilmington, DE 19803
    Telephone
    Telephone
    +1 1.855.446.2983
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.incyte.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    German Wound Congress

    German Wound Congress

    Not Confirmed

    envelop Contact Supplier

    German Wound Congress

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Incyte Launches FDA-Approved Jakafi XRTM For Myelofibrosis & More
    Incyte Launches FDA-Approved Jakafi XRTM For Myelofibrosis & More

    04 May 2026

    // PRESS RELEASE

    https://investor.incyte.com/news-releases/news-release-details/incyte-announces-fda-approval-jakafi-xrtm-ruxolitinib-extended

    PRESS RELEASE
    04 May 2026
    Share Share
    MacroGenics, Sagard Expand ZYNYZ Royalty Purchase Agreement
    MacroGenics, Sagard Expand ZYNYZ Royalty Purchase Agreement

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3286588/0/en/macrogenics-and-sagard-healthcare-partners-enter-into-expanded-zynyz-royalty-purchase-agreement.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share
    Incyte Oration’s Jakafi Xr Receives Approval in US
    Incyte Oration’s Jakafi Xr Receives Approval in US

    01 May 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217180

    FDA
    01 May 2026
    Share Share
    FDA Warns Three Firms For GMP Violations, Cites Incyte
    FDA Warns Three Firms For GMP Violations, Cites Incyte

    30 Apr 2026

    // RAPS

    https://www.raps.org/resource/fda-warns-three-firms-for-gmp-violations-cites-incyte-for-misleading-claims.html

    RAPS
    30 Apr 2026
    Share Share
    Incyte Claims Double Phase 3 Wins in Vitiligo, Plans NDA Filing
    Incyte Claims Double Phase 3 Wins in Vitiligo, Plans NDA Filing

    29 Apr 2026

    // ENDPOINTS

    https://endpoints.news/incyte-claims-double-phase-3-win-in-vitiligo-will-file-for-approval/

    ENDPOINTS
    29 Apr 2026
    Share Share
    Incyte Reports Q1 2026 Results and Business Updates
    Incyte Reports Q1 2026 Results and Business Updates

    28 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260428703817/en/Incyte-Reports-First-Quarter-2026-Financial-Results-and-Provides-Business-Updates

    BUSINESSWIRE
    28 Apr 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search